Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Use of methylation and fragmentation signals in the detection of early-stage colorectal cancer.
Authors
Pol Canal-Noguer
Universal Diagnostics S.L., Sevilla, Spain;
Pol Canal-Noguer , Alejandro Requena Bermejo , Špela Zavodnik , Vivian Erklavec Zajec , Francesco Mattia Mancuso , Marina Manrique López , Primož Knap , Marko Chersicola , Pablo Pérez Martínez , Fernando Trincado Alonso , Carme Nolla Colomer , Kristi Kruusmaa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 201)
DOI
10.1200/JCO.2023.41.4_suppl.201
Abstract #
201
Poster Bd #
L3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): The Brazilian ten year long experience.
First Author: Victor Filogonio
Poster
2022 ASCO Annual Meeting
An ultrasensitive approach for cancer screening and tissue of origin prediction based on targeted methylation sequencing of cell-free DNA.
First Author: Tiancheng Han
Poster
2021 ASCO Annual Meeting
Accurate early-stage colorectal cancer detection through analysis of cell-free circulating tumor DNA (ctDNA) methylation patterns.
First Author: James M. Kinross
Poster
2020 ASCO Virtual Scientific Program
Discovery of a core-panel of markers for a blood-assay for cancer detection utilizing cfDNA methylation changes.
First Author: Lasika Seneviratne